Mycobacterium bovis BCG: the importance of an accurate identification in the diagnostic routine

Antonella Grottola; Anna Fabio; Anna MT Sabbatini; Giuliana Fabio,; Mariagrazia Apice; Alessia Di Nauta; Giulia Forbicini; Annunziata La Regina; Sara Tagliazucchi; Monica Pecorari; Fabio Rumpianesi; Chiara Casolari

doi:10.4081/mm.2010.2428

Mycobacterium bovis BCG: the importance of an accurate identification in the diagnostic routine

https://doi.org/10.4081/mm.2010.2428

PDF

Vol. 25 No. 3 (2010)

Submitted: 14 February 2014
Accepted: 14 February 2014

Published: 30 September 2010

M. bovis BCG, bladder cancer, genotyping MTB complex

Abstract Views: 824

PDF: 993

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

M. bovis BCG is used clinically in the immunotherapy treatment of superficial bladder cancer to prevent progression to invasive disease, leading in some cases to a severe localized inflammation or disseminated infections. For this reason, an accurate and early identification of this particular microorganism is clinically relevant.We describe a case-report of bladder cancer with a urine culture-positive for mycobacteria initially diagnosed as MTB complex infection and later identified as BCG disease by molecular methods.

Grottola, A., Fabio, A., Sabbatini, A. M., Fabio, G., Apice, M., Di Nauta, A., Forbicini, G., La Regina, A., Tagliazucchi, S., Pecorari, M., Rumpianesi, F., & Casolari, C. (2010). Mycobacterium bovis BCG: the importance of an accurate identification in the diagnostic routine. Microbiologia Medica, 25(3). https://doi.org/10.4081/mm.2010.2428